Carla Mamolo

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial

Robert Bissonnette, Kim Papp, Yves Poulin et al. · British Journal of Dermatology · 2016 · 418 citations · Full text

Life Sciences, Dermatology, Pharmacology +15

Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial

Kim Papp, Robert Bissonnette, Melinda Gooderham et al. · BMC Dermatology · 2016 · 98 citations · Full text

Medicine, Dermatology, Pharmacology +11

Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes

Julián Panés, Chinyu Su, Andrew G. Bushmakin et al. · BMC Gastroenterology · 2015 · 95 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Tofacitinib (<scp>CP</scp>‐690,550), an oral Janus kinase inhibitor, improves patient‐reported outcomes in a phase 2b, randomized, double‐blind, placebo‐controlled study in patients with moderate‐to‐severe psoriasis

Carla Mamolo, Jane Harness, Huaming Tan et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 76 citations

Medicine, Dermatology, Pharmacology +13

Increased Cause-specific Mortality in Patients with Mild and Severe Psoriasis: A Population-based Swedish Register Study

Axel Svedbom, Johan Dalén, Carla Mamolo et al. · Acta Dermato Venereologica · 2014 · 68 citations · Full text

Public Health, Dermatology, Health Sciences +15